Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of CPS14217C>A genotype on valproic-acid-induced hyperammonemia.

Pediatrics international : official journal of the Japan Pediatric Society - 1 Oct 2010

Yagi Mariko, Nakamura Tsutomu, Okizuka Yo, Oyazato Yoshinobu, Kawasaki Yoko, Tsuneishi Shuichi, Sakaeda Toshiyuki, Matsuo Masafumi, Okumura Katsuhiko, Okamura Noboru

Abstract excerpt

BACKGROUND: In order to clarify the factors causing hyperammonemia and to predict occurrences during treatment with valproic acid (VPA), we investigated the effect of the genetic polymorphism of carbamoyl-phosphate synthase 1 (CPS14217C>A) on susceptibility of hyperammonemia, together with the ef...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Valproic Acid
Share to Age Distribution
Share to Anticonvulsants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Administration Schedule

Share to Epilepsy

Share to Hyperammonemia

Share to Reference Values

Share to Sex Distribution

Source

Identifiers

PMID: 20456087
DOI: 10.1111/j.1442-200X.2010.03157.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20456087-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of CPS14217C>A genotype on valproic-acid-induced hyperammonemia.PMID 20456087Read ↗

4217C>A polymorphism in carbamoyl-phosphate synthase 1 gene may not associate with hyperammonemia development during valproic acid-based therapy.Semantic proximity Read ↗

Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.Semantic proximity Read ↗

Perioperative exacerbation of valproic acid-associated hyperammonemia: a clinical and genetic analysis.Semantic proximity Read ↗

Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy.Semantic proximity Read ↗

Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.Semantic proximity Read ↗

Effect of UGT2B7 genetic variants on serum valproic acid concentration.Semantic proximity Read ↗

Influence of acylpeptide hydrolase polymorphisms on valproic acid level in Chinese epilepsy patients.Semantic proximity Read ↗

Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy.Semantic proximity Read ↗

Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model.Semantic proximity Read ↗

Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.Semantic proximity Read ↗

Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.Semantic proximity Read ↗

Influence of UGT2B7 and UGT1A6 polymorphisms on plasma concentration to dose ratio of valproic acid in Chinese epileptic children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.